ClinicalTrials.Veeva

Menu
N

New Hope Research Development | Corona, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Contezolid
LY3298176
Contezolid Acefosamil
APL-1401
Deudomperidone
Tirzepatide
CIN-102
Linezolid

Parent organization

This site is a part of New Hope Research Development

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 4 total trials

A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis

This is a randomized, double-blind, placebo-controlled, phase 1b study designed to evaluate safety, tolerability, PK, and preliminary efficacy of APL...

Enrolling
Ulcerative Colitis
Drug: Placebo
Drug: APL-1401
Locations recently updated

The goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help reduce the symptoms associated with diabetic gastr...

Enrolling
Diabetic Gastroparesis
Drug: Placebo
Drug: CIN-102 Dose 15mg or 10mg

This is a Phase 3, multicenter, randomized, double-blind, safety and efficacy study of contezolid acefosamil (IV)/contezolid (PO) compared with linez...

Enrolling
Diabetic Foot Infection
Drug: contezolid acefosamil (IV)/contezolid (PO)
Drug: Linezolid (IV and PO)

Trial sponsors

A
C
Lilly logo
MicuRx logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems